Results 61 to 70 of about 18,622 (204)
Background: There is some evidence for the efficacy of antiplatelet therapies in increasing the vascular access patency duration or decreasing the thrombosis of arteriovenous grafts.
Pouya Tayebi +3 more
doaj +1 more source
Intravenous Dipyridamole: Use in Thallous Chloride TL 201 Stress Imaging
An intravenous form of dipyridamole has been approved for cardiac stress testing with thallous chloride Tl 201 (201Tl) imaging. The procedure provides an alternative method for stress testing of patients who cannot perform strenuous physical exercise ...
Patricia A. Howard
core +1 more source
ABSTRACT Purpose Nursing home (NH) residents are at high risk for major bleeding and are frequently exposed to complex medication regimens that may increase the likelihood of clinically important drug–drug interactions (DDIs). However, DDI evidence from community‐dwelling populations may not generalize to NH residents, and real‐world signals involving ...
Adam M. D'Amico +9 more
wiley +1 more source
The aim of the study was to identify and compare informative values of combined high-dose dipyridamole stress echocardiography (EchoCG) and pair bicycle stress test, or transesophageal atrial pacing (TEAP), in coronary stenosis diagnostics.
A. Yu. Vasilyev, N. N. Mikheev
doaj
Dipyridamole reduces penile apoptosis in a rat model of post-prostatectomy erectile dysfunction
Purpose: Despite the nerve-sparing technique, many patients suffer from erectile dysfunction after radical prostatectomy (RP) due to cavernous nerve injury. The aim of this study was to evaluate dipyridamole as a potential treatment agent of post-radical
Omer Kutlu +9 more
doaj +1 more source
Machine Learning Enables Rapid Prediction of Acid‐Reducing Agent Drug Interactions: A Streamlined Complement to PBPK Modeling. ABSTRACT pH‐dependent drug–drug interactions (DDIs) commonly occur when acid‐reducing agents (ARAs) are co‐administered with weakly basic drugs.
Yuanfang Qin +6 more
wiley +1 more source
Dipyridamole myocardial perfusion imaging
Dipyridamole is a pharmacologic stressor used in place of exercise for myocardial perfusion imaging in patients who cannot exercise due to various physical limitations.
Leppo, Jeffrey A.
core
Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda +5 more
wiley +1 more source
Dipyridamole-induced myocardial ischaemia increases ANF release in man
Atrial natriuretic factor (ANF) release is modulated by several haemodynamic factors, including ventricular and atrial wall stretch. Dipyridamole infusion, which is commonly used as a pharmacological stressor in patients with coronary artery disease, can
Marini C +5 more
core +1 more source
Summary: Background: To evaluate the value of preoperative dipyridamole thallium-201 scintigraphy for reducing cardiovascular complication in secondary hyperparathyroidism (SHPTH) patients.
Shih-min Yin +3 more
doaj +1 more source

